Wave Life Sciences Announces Approval of First Clinical Trial Application for RestorAATion-2 ...

CAMBRIDGE, Mass., April 30, 2024 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,Chelley Casey ,Paul Bolno ,Alicia Suter ,Kate Rausch ,Wave Life Sciences ,Nasdaq ,Twitter ,Wave Life Sciences Ltd ,Linkedin ,Community Contact ,Wave Life Sciences Nasdaq ,Exchange Commission ,Life Sciences ,Chief Executive Officer ,Wave Life ,Private Securities Litigation Reform Act ,Annual Report ,Region ,